In this episode, Dr. Stader and Dr. Bradley summarize and offer key insights for the following Coaches' Top 5 picks, discussing injectable buprenorphine, benzodiazepine tapering, advances in the prevention of migraine, and more!
-
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths, Published in the New England Journal of Medicine, June 2024
-
Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal, Published in JAMA, July 2024
-
Physician Reluctance to Intervene in Addiction: A Systematic Review, Published in JAMA Network Open, July 2024
-
ASAM Guideline on Benzodiazepine tapering, Published by ASAM, July 2024
-
Pharmacologic prevention of migraine, Published in the Canadian Medical Association Journal, February 2023